Department of Radiology

Publications

2020

Jung M, Yang Y, McCloskey JE, Zaman M, Vedvyas Y, Zhang X, et al. Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer. Mol Ther Oncolytics. 2020;18:587-601.

Smith BJ, Buatti JM, Bauer C, Ulrich EJ, Ahmadvand P, Budzevich MM, et al. Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer Images. Tomography. 2020;6(2):65-76.

Solomon E, Liberman G, Nissan N, Furman-Haran E, Sklair-Levy M, Frydman L. Diffusion-weighted breast MRI of malignancies with submillimeter resolution and immunity to artifacts by spatiotemporal encoding at 3T. Magn Reson Med. 2020;84(3):1391-1403.

Balasubramanian PS, Spincemaille P, Guo L, Huang W, Kovanlikaya I, Wang Y. Spatially Adaptive Regularization in Total Field Inversion for Quantitative Susceptibility Mapping. iScience. 2020;23(10):101553.

Pandya S, Kaunzner UW, Rúa SM, Nealon N, Perumal J, Vartanian T, et al. Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions. J Neuroimaging. 2020;30(4):537-543.

Paul DM, Ghiuzeli CM, Rini J, Palestro CJ, Fung EK, Ghali M, et al. A pilot study treatment of malignant tumors using low-dose F-fluorodeoxyglucose (F-FDG). Am J Nucl Med Mol Imaging. 2020;10(6):334-341.

Shen Z, Tung C-. Selective photo-ablation of glioma cells using an enzyme activatable photosensitizer. Chem Commun (Camb). 2020;56(89):13860-13863.

Palta P, Rippon B, Reitz C, He H, Sherwood G, Ceballos F, et al. genotype and in vivo amyloid burden in middle-aged Hispanics. Neurology. 2020;95(15):e2086-e2094.

Zein SA, Karakatsanis NA, Issa M, Haj-Ali AA, Nehmeh SA. Physical performance of a long axial field-of-view PET scanner prototype with sparse rings configuration: A Monte Carlo simulation study. Med Phys. 2020;47(4):1949-1957.

Bellat V, Verchère A, Ashe SA, Law B. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β. BMC Cancer. 2020;20(1):661.